Suche starten De menü de ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20220302
    Veröffentlichungsdatum: 9 Juni 2022

    Projektträger – zwischengeschaltetes Finanzinstitut

    ACCEPTABLE CORPORATE(S)

    Ort

    Beschreibung

    Programme loan comprising venture debt operations eligible under 1.2 Health of the InvestEU Research, Innovation and Digitalisation Window (RIDW).

    Additionality and Impact

    The programme loan meets the InvestEU objectives related to (a) research, development and innovation, (b) financial support to entities employing up to 499 employees, with a particular focus on SMEs, and small mid-cap companies and (c) Social investments, including those supporting the implementation of the European Pillar of Social Rights.


    It involves investments for the research, development, validation, manufacturing and market-entry of innovative technologies and services addressing unmet medical and public needs, suitable to strengthen the EU's position in Health. The EIB financing therefore supports investments addressing the market failure and gaps associated with imperfect competition and incomplete markets for very innovative and early-stage technologies and services, and those associated with positive knowledge, social and environmental externalities generation.


    The projects to be financed under the sub-operations will help the promoters to implement long-term innovation and commercialisation strategies usually entailing high investment risks. The financing will therefore enhance the promoters' technology edge and capabilities, and support the development and deployment of new technologies and innovative, higher value-added products and services addressing unmet medical and public health needs.


    The financing structure is designed to address those high-risk investments, which are requiring long-term capital. A similar financing structure is not available from other market players at comparable terms and/or within the same crucial timeframe. The EIB expertise is also pivotal in quasi-equity transactions, as they involve a highly customised structuring component and frequent monitoring to ensure consistency with policy objectives and implementation milestones.

    Ziele

    Programme loan under InvestEU RIDW General Debt aiming at providing venture debt finance to eligible counterparts in all InvestEU eligible countries.

    Sektor(en)

    • Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
    • Dienstleistungen - Erbringung von Freiberuflichen, Wissenschaftlichen und Technischen Dienstleistungen
    • Gesundheit - Gesundheits- und Sozialwesen

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 750 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 1500 million

    Umweltaspekte

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.

    Auftragsvergabe

    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.

    Projektstatus

    Genehmigt - 13/07/2022

    Haftungsausschluss

    Bis Finanzierungen vom Verwaltungsrat genehmigt und anschließend unterzeichnet werden, befinden sich die Projekte in der Prüfungs- oder Verhandlungsphase. Die Angaben auf dieser Seite sind daher unverbindlich.
    Sie dienen lediglich der Transparenz und stellen nicht die offizielle EIB-Politik dar (vgl. auch die erklärenden Anmerkungen).

    Tags

    EU-Länder Industrie Dienstleistungen Gesundheit